SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-004403
Filing Date
2023-02-23
Accepted
2023-02-23 16:25:23
Documents
14
Period of Report
2023-02-22
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20230223_8k.htm   iXBRL 8-K 35396
2 EXHIBIT 3.1 ex_479825.htm EX-3.1 11231
  Complete submission text file 0001437749-23-004403.txt   186941

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wint-20230222.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20230222_def.xml EX-101.DEF 11916
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20230222_lab.xml EX-101.LAB 15956
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20230222_pre.xml EX-101.PRE 12127
8 EXTRACTED XBRL INSTANCE DOCUMENT wint20230223_8k_htm.xml XML 2659
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 23660034
SIC: 2836 Biological Products, (No Diagnostic Substances)